FDA Issues Emergency Use Authorization for Remdesivir
Remdesivir can be administered intravenously to treat COVID-19 patients with severe disease
COVID-19 Case Fatality Rate Increased for Cancer Patients
Case fatality rates were 37 and 25 percent for hematologic and solid malignancies, respectively
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Large-Vessel Stroke Described in Young Adults With COVID-19
Five patients younger than 50 years presented with large-vessel stroke during two-week period in NYC
Men Have More Serious Disease, Higher Death Rate From COVID-19
Number of men in deceased group was 2.4 times higher than women in public dataset from China
Symptomatic Health Care Staff in U.K. Screened for COVID-19
Shift in transmission dynamics noted as of March 24, concurrent with steps to implement social distancing
Remdesivir May Accelerate Recovery From Severe COVID-19
Early results from NIH study promising, but Lancet study did not show significant clinical benefit
Guidelines Recommended for ECMO Use in Setting of Pandemic
Tiered approach to ECMO response recommended, with focus on increasing capacity during mild surge
Almost All COVID-19 Patients Have Diminished Sense of Smell
98 percent of COVID-19 inpatients exhibited some smell dysfunction on quantitative smell test
Many Health Care Workers Face Risk for Poor Outcomes With COVID-19
26.6 percent of health care workers with patient contact at risk due to age, chronic conditions
